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The interplay of transcription factors and cis-regulatory elements
(CREs) orchestrates the dynamic and diverse genetic programs that
assemble the human central nervous system (CNS) during devel-
opment and maintain its function throughout life. Genetic varia-
tion within CREs plays a central role in phenotypic variation in
complex traits including the risk of developing disease. We took
advantage of the retina, a well-characterized region of the CNS
known to be affected by pathogenic variants in CREs, to establish
a roadmap for characterizing regulatory variation in the human
CNS. This comprehensive analysis of tissue-specific regulatory ele-
ments, transcription factor binding, and gene expression programs
in three regions of the human visual system (retina, macula, and
retinal pigment epithelium/choroid) reveals features of regulatory
element evolution that shape tissue-specific gene expression pro-
grams and defines regulatory elements with the potential to con-
tribute to Mendelian and complex disorders of human vision.
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The human central nervous system (CNS) is composed of di-verse tissues and cell types, whose unique forms and func-
tions arise from their distinct programs of gene expression. The
precise timing, levels, and cell type specificity of gene expression
are controlled by cohorts of cis-regulatory elements (CREs),
including promoters and distal enhancers. These short DNA
sequences (100 to 500 bp) consist of binding sites for sequence-
specific transcription factors (TFs) and function coordinately to
recruit transcriptional machinery to specific sites in the genome
(1). Genetic variation within the sequence of CREs, between
individuals within a population or between species, can lead to
changes in TF binding and thus changes in the expression of linked
gene(s). These regulatory variants are now appreciated to play a
central role in the evolution of species-specific traits and in phe-
notypic variation between individuals including disease (2–6). A
major obstacle toward understanding normal and pathological
consequences of regulatory variation in human tissues is that many
cell type- and tissue-specific CREs have not been comprehensively
mapped in the relevant human tissues. Thus, their functions in de-
velopment and tissue homeostasis remain incompletely understood.
Accordingly, the identification and characterization of CREs have
become a major focus of genetics in the early 21st century (7).
The retina is a classic model for CNS development, function,
and gene regulation because of its highly stereotyped cellular
composition and circuit organization. This reduced cellular di-
versity compared to other CNS regions has recently made the
retina a powerful system for characterizing the mechanisms by
which TFs function at CREs to control the specification and
differentiation of retinal cell types (8–11). The retina consists of six
major cell classes that are specified from a common pool of pro-
genitors during development through the cooperation of broadly
expressed and lineage-defining TFs. The largest fraction of cells in
the human retina are rod photoreceptor cells, which mediate the
earliest steps in vision. The retinal pigment epithelium (RPE) is
directly apposed to mammalian photoreceptor cells and is required
for photoreceptor cell survival and function. The retina and RPE
share an embryonic origin in the early optic vesicle; however, as
mature tissues, they are functionally and molecularly distinct. To-
gether, the retina, the RPE, and the macula, a specialized central
region of the human retina that mediates high-acuity vision, are
commonly affected in human visual disorders. It is therefore im-
portant to understand the genetic regulation of these tissues to
serve as a model of CNS function and disease.
TFs that specify the cell types of the retina and RPE are highly
conserved across species. Mutations in TFs that disrupt gene
expression in specific cell types often result in similar phenotypes
in mice and humans including congenital blindness, photoreceptor
degeneration, ocular malformations, and glaucoma (12–15). It is
unclear, however, to what extent the CREs that recruit these TFs
are conserved between species. Indeed, the evolutionary conser-
vation of CREs is significantly lower than that of protein coding
genes (3). An increasing number of studies show that mutations in
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specific CREs cause retinal disorders (16–18). It is therefore
critical to map and characterize the CREs that regulate essential
gene expression in human eye tissues to refine the genomic
search-space for additional human disease-causing noncoding
mutations. These analyses will also facilitate discovery of the
mechanisms by which TFs selectively bind and activate cell type-
specific CREs to regulate the expression of genes essential for
proper retinal development and function.
In this study, we used an integrated epigenomic approach to
identify and functionally characterize CREs in three tissue re-
gions that are essential for human vision: the retina, macula, and
RPE/choroid. By comparing the epigenetic landscape of these
tissues, we found that tissue-specific CREs are regulated primarily
at the level of differential chromatin accessibility and through
distinct cohorts of TFs. We assessed the genomic binding of five
TFs that are essential for retinal function and found that combi-
nations of TFs are essential rather than being redundant for CRE
function. To investigate the role of TF/CRE interactions in indi-
vidual retinal cell types, we profiled gene expression in >4,000
single human retinal nuclei and identified candidate cell type-
specific CREs. Comparison of human and mouse retinal CREs
demonstrated functional conservation of CREs at essential retinal
genes and highlighted species-specific differences that alter gene
expression. Last, we were able to show that CRE identification can
facilitate the discovery and interpretation of disease-associated
regulatory variation in CREs. These findings provide recent in-
sights into the mechanisms by which regulatory variation shapes
the development of complex neural tissues, species-specific traits,
and disease outcomes affecting human vision.
Results
Identification of Active CREs in Human Visual Tissues. To identify the
specific CREs in the genome that control genes necessary for
human visual function, we first sought to identify shared and
tissue-specific CREs in adult human retina, macula, and RPE/
choroid based on epigenetic features of enhancers and pro-
moters (Fig. 1 A and B). Candidate active CREs in each tissue
type can be defined by the following: 1) accessible chromatin
as a result of TF binding, 2) enrichment for histone modifica-
tions associated with active enhancers or promoters, and 3) as-
sociation with active gene expression (Fig. 1B). These principal
features of CREs were profiled and examined for subse-
quent analyses in this study (Fig. 1C). Chromatin accessibility
was determined using assay for transposase-accessible chromatin
sequencing (ATAC-seq) (19) on nuclei purified from adult
postmortem unfixed human retina and macula (Fig. 1D and SI
Appendix, Fig. S1A). DNase-seq datasets were used to iden-
tify chromatin accessibility in RPE (20) (Fig. 1D). A read-
normalized comparison of ATAC-seq vs. DNase-seq in mouse
retinal tissue demonstrated correlation (r2 = 0.69) and suggested
these assays are generally comparable for purposes of identifying
regions of DNA accessibility (SI Appendix, Fig. S1 B and C). To
distinguish active CREs from other accessible regions, we colo-
calized accessible regions with the histone mark consistent with
active enhancers and promoters, acetylated lysine 27 on histone
3 (H3K27ac), using chromatin immunoprecipitation sequencing
(ChIP-seq) (21, 22). Altogether, we identified 21,368, 19,933,
and 12,212 regions that were enriched for DNA accessibility and
H3K27ac in the retina, macula, and RPE/choroid, respectively
(Fig. 1D and Dataset S2). To facilitate the use of these data in
basic and disease research, we have assembled them, and addi-
tional data described below, into a searchable track hub via the
University of California, Santa Cruz (UCSC) genome browser
(https://tinyurl.com/CherryLab-EyeBrowser) (SI Appendix).
Active CREs engage transcriptional machinery to promote
target gene expression. To confirm that these identified regions
are associated with active gene expression in each tissue, we
performed RNA sequencing (RNA-seq) on adult human retina,
macula, and RPE/choroid. RNA-seq was performed on total RNA
extracted from cell nuclei (total RNA Nuc-seq), to avoid cross
contamination of RNA between the intercalated cells of the retina
and RPE/choroid, and to enrich for enhancer RNAs (eRNAs), a
marker of active enhancers (23). We then compared the level of
proximal gene expression to the level of H3K27ac at putative
enhancers and promoters. We found that levels of H3K27ac are
correlated with levels of proximal gene expression (Fig. 1 D and E
and SI Appendix, Fig. S1D). Highly expressed genes associated
with active CREs in each tissue include the known disease genes
RP1, ABCA4, and RPE65 in retina, macula, and RPE/choroid,
respectively (Fig. 1F). At each of these gene loci, proximal pro-
moters and one or more distal enhancers were identified based on
the co-occurrence of DNA accessibility, H3K27ac signal, and,
when present, eRNAs. The correlation of each of these assays was
quantified between biological replicates and across tissues to as-
sess reproducibility and tissue specificity (SI Appendix, Fig. S1A).
Active enhancers and promoters in each tissue contribute to
the unique programs of gene expression and biological function of
each tissue. To determine the distinct biological functions asso-
ciated with active enhancers and promoters in each tissue, we
performed genome regions enrichment of annotations (GREAT)
analysis (24). We found CREs in the retina and macula to be
significantly associated with regulation of rhodopsin signaling and
the cellular response to light, consistent with the abundance of
photoreceptor cells in both tissues (Fig. 1G). Active regulatory
elements in the RPE/choroid, however, were associated with
regulation of ion transporter activity, an essential function of RPE
to compensate for light-dependent changes in photoreceptor ca-
pacitance (25, 26). This analysis also uncovered association of
active CREs with distinct pathologies in each tissue including
night blindness, abnormal retinal vasculature, and abnormalities of
the vitreous in retina, macula, and RPE, respectively.
To validate the transcriptional activity of CREs identified
using this integrated epigenomic approach, we cloned candidate
CREs from the human ABCA4 Stargardt disease gene locus (SI
Appendix, Fig. S1E) into a luciferase reporter construct and
electroporated these constructs individually into the postnatal day
0 (P0) mouse retina and harvested at P11 as ABCA4-expressing
photoreceptor cells are maturing. Although this approach is not
sufficient to determine the expected photoreceptor cell-specific
activity of these enhancers, we did observe that the majority of
these identified CREs (six of eight) increased the transcriptional
output of the reporter construct when compared to the empty
vector control, suggesting that these elements have intrinsic CRE
activity (SI Appendix, Fig. S1F). Taken together, these integrative
epigenomic and transcriptomic analyses demonstrate that active
regulatory elements contribute to unique biological processes in
the human retina, macula, and RPE/choroid. Disruption of these
regulatory elements by genetic variation could have tissue-specific
consequences resulting in visual disorders. The results of these
analyses have now defined the sites in the genome in which to look
for cis-regulatory variants implicated in disease.
Tissue-Specific Gene Expression Is Shaped by DNA Accessibility of
CREs. The retina, macula, and RPE share a common embryonic
origin in the nascent optic vesicle; however, each tissue performs
a distinct function in adult vision. Most CRE accessibility is
shared between retina and macula (68% and 69%, reciprocally),
likely due to the shared cell types that make up these tissues (Fig.
2A). In contrast, only a fraction of their DNA-accessible sites
is shared with RPE/choroid (23% and 17% reciprocally). This
suggests that retina vs. RPE/choroid CREs are generally main-
tained by differential DNA accessibility. Among CREs that are
accessible in all tissues, most also share H3K27ac enrichment (65%)
(Fig. 2B). This shows that while tissue-specific CRE activation
does occur, differential accessibility is the dominant pattern of
tissue-specific CREs. Examples of both modes of regulation can
be observed at the human disease gene loci PRPH2, RPE65, and
ABCA4 (Fig. 2 C and D and SI Appendix, Fig. S2A).
Intriguingly, genes that are expressed in both retina and RPE
can also employ tissue-specific CREs giving each tissue “private”
control over shared genes. For example, we found that ABCA4, the
mutated gene in autosomal recessive Stargardt disease (STGD1)
9002 | www.pnas.org/cgi/doi/10.1073/pnas.1922501117 Cherry et al.
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was expressed in both human RPE and retina (SI Appendix, Fig.
S2A). One upstream enhancer (1) that is highly active in the retina
(SI Appendix, Figs. S1 E and F, S2A, and S3 D and E) is accessible
in RPE, but not enriched for H3K27ac. In contrast, two intronic
enhancers (7′ and 8′) are accessible and enriched for H3K27ac in
RPE/choroid, but not in retina or macula. Independent regulation
of disease gene expression by tissue-specific CREs offers one
possible explanation for variability seen in human disease phe-
notypes among individuals with commonly affected genes.
Whether tissue-specific CREs are primarily regulated at the
level of accessibility or activation, the end result should be tissue-
specific differences in gene expression. To confirm this, we first
identified tissue-specific CREs by comparing levels of H3K27ac
between each tissue (Fig. 2E). Next, we compared the expression
of genes associated with these differentially active CREs (Fig.
2F). We found that, as a population, genes associated with tissue-
specific CREs demonstrated a tissue-specific pattern of expres-
sion. These observations underscore the role of differentially
active CREs in driving distinct programs of gene expression to
impart unique biological functions to each tissue.
CRE Output Is Determined by Combinatorial TF Binding. Ultimately,
TFs determine the accessibility, activity, and function of CREs.
Furthermore, genetic variants within CREs that disrupt TF binding
motifs may lead to misregulated gene expression and disease. It is
therefore important to investigate the individual and combina-
torial contributions of TFs to CRE function. We first sought to
determine which TFs might bind to CREs in human retina,
macula, and RPE/choroid by performing motif enrichment
analysis using the HOMER software package (27). In the retina
and macula, HOMER found significant enrichment of motifs
matching the dimeric OTX2 and CRX (K50 homeodomain),
MAF (basic region, leucine zipper), ROR (nuclear receptor),
and MEF2 (MADS) TF family consensus binding motifs,
whereas in RPE AP-1, MITF, TEAD, OTX2, and CRX motifs
were enriched (Fig. 3A). Members of these TF families have
evolutionarily conserved roles in retinal and/or RPE function
and can lead to human visual disorders when mutated (14, 28).
However, the combinatorial action of these TFs in the human
retina is not well understood.
Motifs are only predictive of TF binding and do not unam-
biguously identify TFs, as multiple TFs may bind to similar
motifs. Therefore, it is important to investigate directly how the
binding and activity of TFs relate to human CRE function. We
focused on the adult human retina and performed ChIP, fol-
lowed by high-throughput sequencing (ChIP-seq) for five TFs
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Fig. 1. Identification and characterization of active
cis-regulatory elements (CREs) in human retina, mac-
ula, and RPE. (A) Schematic cross-section of the human
eye with tissues commonly affected in inherited reti-
nal diseases labeled. (B) Schematic of cis-regulatory
control of gene expression. Transcription factors (TF1–
5) bind in combination to promoters and enhancers to
recruit cofactors including histone acetyl transferases
(HATs) and basal transcriptional machinery such as RNA
polymerase (PolII). HATs acetylate lysine residues on
histones, including H3K27ac (Ac). PolII can induce
transcription of enhancer RNAs (eRNAs). Both H3K27ac
and eRNAs are associated with active CREs. (C) Sche-
matic of study workflow. (D) Genome-wide DNA ac-
cessibility and H3K27ac in adult human retina, macula,
and retinal pigment epithelium (RPE) and choroid, by
the assay for transposase accessible chromatin (ATAC),
DNase-seq, and H3K27ac ChIP-seq. Each accessible ge-
nomic region (ATAC or DNase-seq) is represented as a
single horizontal line centered on the peak summit,
with a window of ±1 kb. ATAC or DNase-seq signal is
plotted in gray. H3K27ac ChIP-seq signal is plotted in
green. For each tissue, windows of DNA accessibility
and H3K27ac are ordered on highest to lowest total
H3K27ac signal within the 2-kb window. For retina
analyses, ATAC n = 8 samples from unrelated adults,
H3K27ac n = 3, and RNA-seq n = 7. For macula analy-
ses, ATAC n = 3, H3K27ac n = 3, and RNA-seq n = 3. For
RPE analyses, DnaseI-seq n = 2, H3K27ac n = 2, and
RNA-seq n = 3. (E) Expression of genes associated with
DNA-accessible regions in adult human retina (seven
individuals), macula (three individuals), and RPE/cho-
roid (three individuals) as determined by sequencing
total RNA from nuclei (Nuc-seq). Genes are ordered
according to their corresponding accessible regions
from D. (F) Representative gene loci showing custom
UCSC browser tracks for ATAC-seq or DNase-seq,
H3K27ac ChIP-seq, and total RNA Nuc-seq from adult
human retina, macula, or RPE/choroid. (G) Enrichment
of biological processes and phenotypes associated
with candidate active CREs in each tissue according
to analysis using the genome regions enrichment of
annotations tool (GREAT) (24).
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whose motifs were highly enriched among retinal CREs: CRX,
OTX2, NRL, RORB, and MEF2D. Antibodies were selected
according to previous validation in the literature (8–11, 29).
Three biological replicates were performed for each antibody
unless two validated antibodies were available, in which case two
biological replicates were performed per antibody. Anti-RORB
antibody was only available in limited amounts, and therefore
only the top 30% of total peaks were considered for further
analysis that matched similar numbers of peaks found genome-
wide with the other TFs. In each case, high confidence ChIP-seq
peaks were identified across biological replicates using the
ENCODE Consortium’s irreproducible discovery rate (IDR) pipe-
line with a threshold of 1% (30). For each of the five assayed TFs,
we found that TF protein binding was highly enriched at these
active CREs in the adult human retina compared to shoulder
regions and genome-wide chromatin input controls (Fig. 3B).
To validate the specificity of these antibodies, we performed
reciprocal motif analysis for all regions bound by each TF
according to ChIP-seq. In each case, we found that the specific
motif corresponding to the antibody-targeted TF was
significantly enriched (SI Appendix, Fig. S3A). Additionally, we
found that the K50 homeodomain TF motif (e.g., CRX, OTX2)
was also highly enriched for all TF-bound regions, suggesting
that CRX and/or OTX2 cobind with these other TFs at human
retinal CREs. Alternatively, this motif may simply be indis-
criminately enriched at sites of binding for any TF in the retina.
To distinguish between these possibilities, we performed ChIP-seq
for additional factors CTCF and CREB that are not known to
directly regulate photoreceptor cell gene expression. Regions
bound by these TFs were highly enriched for their own motifs but
did not demonstrate enrichment for the K50 homeodomain con-
sensus motifs, suggesting that CRX and OTX2 are acting on a
specific subset of retinal CREs (SI Appendix, Fig. S3A). These
findings are further supported by previous studies of CRX and
CTCF binding in the mouse retina (31, 32). Taken together, these
results support the specificity of the antibodies used for these ex-
periments and underscore the combinatorial function of CRX and
OTX2 with other TFs in establishing and maintaining photore-
ceptor enhancers (8, 33).
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Fig. 2. Differential CRE accessibility drives unique
patterns of gene expression in human retina, macula,
and RPE. (A) Overlap of DNA-accessible genomic re-
gions in adult human retina, macula, and RPE/cho-
roid. (B) Overlap of H3K27ac-enriched genomic
regions that share DNA accessibility in adult human
retina, macula, and RPE/choroid. (C and D) Repre-
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H3K27ac ChIP-seq, and total RNA Nuc-seq from adult
human retina and RPE/choroid. (E) Pairwise com-
parison of H3K27ac signal among DNA-accessible
regions from adult human retina, macula, and RPE/
choroid (blue, RPE enriched; green, retina enriched;
purple, macula enriched). (F) Cumulative distribution
of gene expression associated with tissue-specific
DNA-accessible/H3K27ac regions.
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To examine the relationship of individual TF binding and
CRE activity, we ranked human retinal CREs from most active
to least active according to H3K27ac enrichment (Fig. 3B). We
found that the binding of some TFs (OTX2, NRL, MEF2D) was
positively correlated with H3K27ac levels, suggesting that these
TFs or combinations of these TFs may be activating. Oppositely,
binding of CRX was highest at the bottom quintile of H3K27ac
levels. This suggested that CRX can mediate CRE repression in
the mature human retina or is at least bound to inactive sites in
the genome (Fig. 3B and SI Appendix, Fig. S3 B–D). To further
examine these sites, we performed ChIP-seq for an additional
histone mark H3K4me2, which is enriched at CREs that are
either active (H3K27ac-enriched) or potentially poised (H3K27ac-
low) (Fig. 3B). Sites at which CRX is bound, but H3K27ac is low
are still positive for H3K4me2, suggesting that these sites are silent
or poised CREs. Furthermore, a repressive role for CRX at some
CREs is consistent with a recent study in the mouse retina using
massively parallel reporter assays (33). In future studies, additional
support for this hypothesis could be gained by comparing CRX
binding to marks of repressive chromatin such as H3K27me3. At
present, however, this study, as well as others (8), demonstrates
that when CRX binds together with other TFs, the effect can
be activating. These observations underscore the significance of
combinations of TFs in regulating CREs to promote or repress
gene expression.
To assess the significance of specific combinations of TF
binding to different aspects of CRE regulation, we determined
levels of DNA accessibility, H3K27ac enrichment, and nearby
gene expression for each permutation of TF binding for five TFs
(SI Appendix, Fig. S3 B–D). Using the Brown–Forsythe ANOVA
test with a Dunnett correction for multiple comparisons, after
removing outliers, we identified significant differences among
differentially bound CREs for each feature (ATAC: F = 484.9
[df = 29,603], P < 0.0001; H3K27ac: F = 157.5 [df = 39,921], P <
0.0001; RNA: F = 83.98 [df = 32,454], P < 0.0001). Among
significant pairwise differences, we found that, as a population,
sites where CRX binds without the other assayed TFs have sig-
nificantly lower levels of DNA accessibility, lower levels of
H3K27ac, and lower levels of associated gene expression. These
sites, however, are enriched for H3K4me2, the epigenetic mark
of enhancers and promoters (Fig. 3B). This suggests that such
sites may be maintained in a poised manner, possibly as a ves-
tige of development or as CREs primed to mediate a stimulus-
dependent transcriptional response. We did not identify consis-
tent trends across other specific combinations of TF binding that
correlated with levels of accessibility, H3K27ac, or nearby gene
expression. Taken together, this would suggest that regulation of
human retinal CREs is heterogeneous and flexible as opposed to
fixed according to an invariant order of TF binding. Among models
of CRE regulation that have been proposed, these data are more
consistent with a flexible “billboard” model of TFs that regulates
gene expression rather than an enhanceosome with a fixed spacing
and configuration of TF binding and regulation (34).
To further investigate the significance of TF cobinding and to
examine the DNA sequence requirements of human CREs, we
returned to the ABCA4 locus. Determining sequence require-
ments for CREs is key to interpreting the effect of genetic var-
iants within CREs that may cause disease. Multiple TFs bound to
a single CRE may additively or synergistically regulate target
gene expression. Alternatively, these TFs may act in a redundant
manner to ensure robustness against genetic or cellular pertur-
bations. To distinguish among these possibilities, we mutated
individual TF binding motifs at this single, highly active enhancer
that binds all five of the TFs that we have examined (Fig. 3D).
Instead of ensuring robustness, we found that disruption of in-
dividual motifs had a profound effect on CRE activity (Fig. 3E).
Even motifs that occurred multiple times within the same CRE
like the shared K50 homeodomain motif (CRX/OTX2) were not
redundant. The only motif that did not appear to be required for
full CRE function was the nuclear receptor (likely bound by
RORB) motif. These observations are notable as they show that
each TF binding event at this highly active enhancer is contrib-
uting in a nonredundant manner to enhancer activity, and that
CRX appears to function as a transcriptional activator in this
context. Taken together, we find that the combination of TFs that
bind to individual enhancers can significantly affect CRE activity.
This activity may be regulated at the level of DNA accessibility, or
CRE activation, and can interact with additional CREs to affect
target gene expression. These observations are informative for
interpreting the impact of genetic variation within human CREs.
Deconvolution of Cell Type-Specific Gene Regulation. The signal
arising from epigenomic assays performed on the intact retina is
likely a function of the abundance of each cell type within the
tissue and the strength of the signal within that cell type.
Nonetheless, cell type-specific CREs may still be identified by
focusing attention on CREs associated with cell type-specific gene
expression (35). The abundance of different cell types in the hu-
man retina and the patterns of cell type-specific gene expression,
however, have not been extensively characterized. Single-cell
RNA-seq is a powerful tool to deconvolve cell types in complex
tissues including the retina (36–39). To identify cell type-specific
CREs, we first sought to determine the abundance of different cell
types in the human retina and to identify cell type-specific gene
expression in human retinal cells. Then, with knowledge of the
genes that are selectively expressed in a given cell type, it should
be possible to assign the nearby CREs to that cell type.
We optimized the protocol of Klein et al. (37) to profile in-
dividual cell nuclei (single-cell Nuc-seq) from adult human ret-
inas from three unrelated individuals (Fig. 4A). By profiling
RNA from single nuclei, we avoid transcriptional contamination
caused by cell-to-cell contacts and obtain a more accurate snap-
shot of active transcription. This also obviates the need for intact,
living cells because intact nuclei can be efficiently isolated from
flash-frozen human tissue, making it possible to use stored tissue
from biobanks. Our single-cell sequencing data were analyzed
using Seurat, version 3.0 (40, 41). After cell-free droplets, dou-
blets, and cells with high mitochondrial reads were removed, 4,763
cells remained. We then identified clusters of cells that, based on
expression of known marker genes, corresponded to all major cell
classes of the mature retina including rod and cone photorecep-
tors, horizontal, bipolar, Müller glial, amacrine, and retinal gan-
glion cells (Fig. 4A) (42–47). These classes were identified
retrospectively based on patterns of known marker gene expres-
sion (SI Appendix, Fig. S4A). Rod photoreceptor cells were the
most abundant class of cells profiled, suggesting that the majority
of the ATAC-seq and ChIP-seq signal originates from epigenomic
features in this cell type (Fig. 4B). However, the abundance of
other cell classes in the human retina was higher than that of
nonrod cells observed from single-cell analysis of the mouse retina
(36). Notably, cone photoreceptor and horizontal cells made up a
larger percentage of all cells in the human retina compared to
mouse, consistent with classical neuroanatomical studies of ro-
dents and primate and rodent retinas (48).
To determine whether candidate cell class-specific CREs could
be identified, we verified the expression of cell class-specific
marker genes in our single–Nuc-seq dataset (SI Appendix, Fig.
S4A). We then examined these individual loci in our dataset to
assess DNA accessibility, histone modifications, and TF binding
(SI Appendix, Fig. S4B). We found that the following cell class
markers maintained their specificity of enrichment in the hu-
man retina and had observable signatures of CREs at their gene
loci: RP1 and NR2E3 (rod photoreceptors), ARR3 and PDE6H
(cones), ONECUT2 (horizontal cells), VSX2, PRKCA, and
GRM6 (bipolar cells), CLU and APOE (Müller glial cells),
GAD1 (amacrine cells), SCL17A6/NEFL (Ganglion cells), and
GFAP (astrocytes) (Fig. 4 and SI Appendix, Fig. S4). These genes
represent markers of broad classes of cells in the retina. To de-
termine whether CREs associated with lowly abundant cell types
were identifiable in our dataset, we analyzed gene loci of cone
photoreceptor cell type markers OPN1LW and OPN1SW. Each of
these gene loci demonstrated nearby accessible regions. In the case
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of OPN1SW, the promoter region was accessible with binding of
CRX, OTX2, and MEF2D. At the OPN1LW/MW region, the well-
studied upstream locus control region (LCR) (49) was clearly ac-
cessible and binding of CRX, OTX2, and MEF2D was observed
(Fig. 4D). Together, these findings suggest that candidate cell class-
and cell type-specific regulatory elements can be identified in these
integrative datasets, although they are generated using heteroge-
neous retinal tissue, even from cell types that represent a small
fraction of the total tissue. Newly available single-cell assays of
DNA accessibility and histone modifications should ultimately be
used to directly test the proposed specificity of these CREs.
To examine the profile of cell class-specific genes associated
CREs as a population, we identified the top 100 most-enriched
genes expressed in each cell class whose promoter regions dem-
onstrated accessibility by ATAC-seq (SI Appendix, Fig. S4C). We
then quantified the ATAC-seq and H3K4me2 and H3K27ac
ChIP-seq signal at the promoters of these genes (SI Appendix, Fig.
S4C). For each cell class-enriched cohort, we observed enriched
H3K27ac and H3K4me2. Together, these data suggested that
epigenetic features of cell class-specific promoters can be observed
in datasets collected from intact tissue.
Conservation and Evolution of Cell Type-Specific Regulatory Elements.
CREs are important substrates of evolutionary change (3). To
assess whether conserved retinal architecture is reflected in
the genome in the form of conserved CREs, we examined the
conservation between human and mouse CREs at critical visual
genes. We first compared the number and topography of candi-
date enhancers at the mouse and human Rhodopsin locus.
Rhodopsin is a G-protein–coupled receptor, essential for rod
cell phototransduction in all mammals. It is also among the most
commonly mutated genes in human inherited retinal disorders
(12). We observed remarkable conservation of regulatory element
topography between mice and humans despite extensive evolu-
tionary divergence between the two species (Fig. 5A). This topo-
graphic conservation is evident from the number and relative
location of individual CREs at the RHO locus. Additionally, the
pattern of TF binding to each CRE appears also to be conserved
with the exception of MEF2D, which appears to be present at
CREs at the human, but not mouse RHO locus. Despite this
topographic conservation, the conservation of DNA sequence
is limited to discrete regions within each CRE (SI Appendix, Fig.
S5A). This suggests that regulatory conservation can be main-
tained in the absence of extensive DNA sequence conservation
and that more specific conservation at the level of individual TF
binding sites is likely what maintains functional conservation.
To assess conservation of regulatory elements at a gene
expressed in a less abundant cell type, we analyzed the CABP5
locus, a calcium binding protein that is an established marker of
bipolar cells in the mouse retina (50). CABP5 was originally
identified as sharing homology to calmodulin and is closely re-
lated to CABP4, which is associated with inherited retinal dis-
orders (51, 52). A proximal promoter and a downstream enhancer
are evident in both mouse and human retinas (Fig. 5B). The to-
pography of these elements with respect to the CABP5 coding
sequence is conserved; however, the binding of TFs is not. Only
OTX2 was bound to the mouse promoter and enhancer, while the
human promoter and enhancer have acquired binding of CRX,
OTX2, NRL, MEF2D, and RORB. Among these factors, CRX
and NRL are enriched in rod photoreceptors, suggesting that this
gene may be differentially regulated in the human retina. To de-
termine whether the regulation of CABP5 has been altered be-
tween the mouse and human retina, we analyzed our human
single-cell transcriptome data and compared these to single-cell
data acquired from the mouse retina (36). In mouse, Cabp5 ex-
pression is largely restricted to bipolar cells, whereas it is
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Fig. 4. Deconvolution of cell type-specific regula-
tory elements. (A) t-Stochastic neighbor embedding
(tSNE) plot of global gene expression of 4,763 single
nuclei from adult human retinal cell nuclei; nuclei are
colored according to 14 unsupervised clusters. (B)
Proportion of cell classes in the human retina iden-
tified according to known marker gene expression in
single retinal nuclei (n = 3 biological replicates) (SI
Appendix, Fig. S4A). (C) Marker gene expression of
individual photoreceptor cell types (RP1, rod; PDE6H,
pan-cone; OPN1LW, long-wavelength [red] cones;
OPN1SW, short-wavelength [blue] cones). (D) Epige-
netic features at photoreceptor cell type-specific
marker gene loci shown by custom UCSC browser
tracks for ATAC-seq, H3K4me2, H3K27ac, and TF
ChIP-seq and total RNA Nuc-seq from adult human
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expressed in bipolar cells and rod photoreceptors in the human
retina (Fig. 5 C–F). Of note, a 54-bp low-complexity (CT) insert in
the downstream mouse enhancer may prevent the recruitment of
other TFs (SI Appendix, Fig. S5B). Together, these observations
show that interspecies differences in gene expression can occur
through sequence divergence in promoters and enhancers to affect
not just the activity of a gene, but also its cell type specificity.
Developmentally Dynamic CREs Underlie Distinct Biological Functions,
Pathologies, and Regulatory Mechanisms. CREs are highly dynamic
during tissue development and regulate discrete processes including
proliferation, specification, and differentiation (35, 53). To in-
vestigate the genetic regulation of these processes in the human
retina, we sought to identify developmentally dynamic CREs. Fur-
thermore, visual disorders can arise from gene misregulation during
retinal development as well as in the adult retina. It is therefore
important to consider developmentally dynamic CREs in conjunc-
tion with adult CREs when searching for disease-causing variants.
At 10 to 12 wk of human fetal development (70 to 84 d), the
earliest born cell types, the retinal ganglion cells and cone
photoreceptors, are beginning to differentiate. By 14 to 17 wk,
most neurons of the retina have left the cell cycle and the latest-
born cell types including rod photoreceptors are differentiating
(98 to 119 d) (54, 55). We compared chromatin accessibility in
the adult human retina to that of the developing retina at these
two critical stages (20, 53).
Clustering of chromatin accessibility data from these distinct time
points revealed three specific patterns that dominated the landscape
of developmentally dynamic DNA accessibility (Fig. 6A). The
majority of sites observed at any time point was shared between
the two developmental time windows but was closed in the adult
retina (21,828/44,510: 49%). For example, enhancers upstream of
the ATOH7 gene locus, which is required for the differentiation of
early-born retinal ganglion cells and has recently been shown to
regulate aspects of rod vs. cone cell fate in the human retina,
exhibited this pattern of chromatin accessibility (Fig. 6B) (16, 56).
There was also a substantial fraction of CREs that were consti-
tutively open across all time points (16,302/44,510: 36.63%) and
CREs that were only accessible in the adult differentiated retina
(5,518/44,510: 12.40%), such as those found at the RHO locus
(Fig. 6C). Very few regions were specific to either developmental
window (10 to 12 wk, 378 [0.85%], or 14 to 17 wk, 346 [0.78%]) or
shared between the late developmental window and adult retina
(110 [0.25%]). As expected, almost no sites were accessible in a
discontinuous pattern, i.e., present at 10 to 12 wk and adult, but
absent from 14 to 17 wk (28 [0.06%]). These patterns suggest
highly transient transcriptional programs that are active in human
retinal development and demonstrate that CREs continue to be
licensed and decommissioned as cells mature.
Identification of dynamic chromatin accessibility is necessary
to completely define the genomic search space for CRE variants
that cause disorders of human visual development. To explore
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this further, we examined developmental chromatin accessibility
at two CREs associated with human disease-causing enhancer
mutations. Individuals who are homozygous for a deletion of a
distal enhancer of ATOH7 are blind from birth and demonstrate
congenital retinal nonattachment (16). Importantly, we found
that there are actually two regions of DNA accessibility in the
developing human retina encompassed within this deleted region,
suggesting that two, not just one, enhancer elements are lost in this
disorder (Fig. 6B). Additionally, an individual with a de novo
monoallelic mutation at a PAX6 autoregulatory site demonstrates
the congenital eye malformation aniridia and absence of a fovea
(17). We found that this point mutation also falls within a region
of DNA accessibility present during development (SI Appendix,
Fig. S6A). Neither of these enhancers demonstrates accessibility in
the adult retina, suggesting that a distinct cohort of genomic re-
gions should be used to search for genetic defects causing de-
velopmental disorders rather than disorders that manifest later
in life. In contrast, a third disease-associated variant, single-
nucleotide polymorphism (SNP) rs17421627, has been shown to
cause developmental retinal vascular abnormalities and is strongly
associated with macular telangiectasia type 2 (57, 58). This point
mutation falls within an enhancer that is accessible both de-
velopmentally and in the adult retina, suggesting how it can con-
tribute to both developmental and later-onset retinopathies (SI
Appendix, Fig. S6B).
The distinct patterns of chromatin accessibility in the developing
vs. the adult retina further suggest that these elements serve different
biological functions and may impinge upon distinct pathologies. We
found that regions of accessible chromatin in the developing retina
were significantly associated with the biological processes of stem
cell maintenance, embryonic camera-type eye morphogenesis, and
negative regulation of glial development. Adult-specific accessibility,
however, was significantly associated with light detection and pho-
totransduction. Apart from DNA accessibility at the ATOH7 and
PAX6 enhancers, no human disease phenotype terms were associ-
ated with regions that are open exclusively in the developing retina.
In contrast, adult-specific accessible regions were significantly as-
sociated with abnormality of the RPE, retinitis pigmentosa, ab-
normal retinal pigmentation, and retinal dystrophy (Fig. 6D).
Distinct patterns of DNA accessibility across retinal develop-
ment are likely driven by distinct cohorts of TFs. To identify
potential regulators of these distinct elements, we looked for
known TF DNA binding motifs that were enriched within de-
velopmental- or adult-specific accessible regions or within re-
gions that are constitutively accessible. Among the top motifs
enriched for developmental-specific accessibility are those that
are assigned to CTCF, LHX, and SOX family TF (Fig. 6E). LHX
and SOX TF families have well-documented roles in the main-
tenance of progenitor cells during retinal development (59).
CTCF is best known for its association with transcriptional
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Fig. 6. Developmentally dynamic DNA accessibility
underlies distinct biological functions, pathologies,
and regulatory mechanisms. (A) Dynamic DNA ac-
cessibility during human retinal development. Each
accessible genomic region (ATAC or DNase-seq) is
represented as a single horizontal line centered on
the peak summit, with a window of ±1 kb. ATAC
(adult) or DNase-seq (developing) signal is plotted in
black. For each developmental stage, windows of
DNA accessibility are ordered on highest to lowest
total accessibility signal. (B and C) Developmentally
dynamic DNA accessibility at the ATOH7 (B) or Rho-
dopsin (C) gene loci displayed as custom UCSC
browser tracks for DNase-seq (developing) or ATAC-
seq (adult) from a time course of human retinal de-
velopment and CTCF, H3K4me2, and H3K27ac ChIP-
seq and total RNA Nuc-seq from adult human retina
(red box, 6.5 kb deleted ATOH7 enhancer region
resulting in inherited human nonsyndromic congen-
ital retinal nonattachment; NCRNA; ref. 16). (D) En-
richment of biological processes and phenotypes
associated with developmentally dynamic candidate
CREs in the human retina according to analysis with
the genome regions enrichment of annotations tool
(GREAT). (E) TF binding motif enrichment at regions
that are accessible in developing or adult human
retina.
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insulators and is also the topmost enriched motif within the
constitutively accessible regions. In the adult-specific accessible
regions, the top-most enriched motifs are assigned to the TFs
CRX, OTX2, MEF2D, and ROR, which are all known to be es-
sential for proper photoreceptor cell differentiation and function
(Fig. 6E). Consistent with these analyses, we established that the
patterns of TF binding were highly concordant with the motif
enrichment and specificity of these distinct regions (SI Appendix,
Fig. S6C). CRX, OTX2, MEF2D, and RORB were more fre-
quently bound at adult-specific regions compared to constitutively
accessible regions. CTCF, in contrast, was more robustly bound to
constitutively accessible regions compared to regions specifically
accessible in the adult retina.
Taken together, these findings show that unique networks of
TFs function at dynamic CREs to regulate stage-specific gene
biological functions, whereas the binding of CTCF at putative
insulator elements appears to be largely static and is specified
early in human retinal development. Furthermore, these data
demonstrate that identified CREs in the human retina overlap
with known disease-causing regulatory element mutations. This
observation serves as an important proof of concept that map-
ping CREs can help define the genomic search-space for novel
variants that may influence human vision.
Identification and Characterization of Functional Variants within
Human cis-Regulatory Regions. To prioritize the search for novel
noncoding variants that affect human vision, we first identified
CREs associated with known retinal disease genes (12) (Fig. 7A).
Of 253 disease genes, we identified 763 enhancers and promoters
(Dataset S3). Genetic variants within these regulatory elements
could contribute to disease phenotypes by misregulating the ex-
pression of these disease-associated genes.
If genetic variants within these CREs are deleterious, then such
variants should be rare in the general human population. In support
of this concept, a recent study demonstrated a depletion of variants
at CRX-bound sites between genetically divergent mouse strains
(60). To assess this in humans, we determined the frequency of
SNPs and indels (insertions and deletions) within human retinal-
disease gene CREs from ∼15,500 unrelated individuals without vi-
sual disorders (61). We found that indels were strongly depleted in
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Fig. 7. Disease gene-associated CREs and noncoding
variation. (A) Heatmap of human retinal disease
gene expression by tissue type. (B) SNP and indel
frequency at disease gene-associated CREs (gnomAD,
MAF 0.01) (8,685 indels, 15,306 SNPs). (C) The RDH12
gene locus showing custom UCSC browser tracks for
ATAC-seq, H3K4me2, H3K27ac, and TF ChIP-seq and
total RNA Nuc-seq from the adult human retina.
Presumptive promoter region highlighted in gray.
(D) Consensus DNA sequence centered around pro-
moter ATAC-seq peak summit. Single-nucleotide
variants (SNVs) (red with black highlight) found in
unrelated individuals with Leber congenital amau-
rosis/retinitis pigmentosa. (E) Luciferase reporter as-
say comparing the relative activities of RDH12
consensus and variant promoter constructs (***P <
0.0005).
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the 200 bp centered on the peaks of chromatin accessibility com-
pared to flanking regions (Fig. 7B). In contrast, no significant de-
pletion of SNPs was observed, consistent with a higher tolerance for
single base changes at CREs. Even so, several reports demonstrate
that single base changes within CREs can have profound effects on
enhancer function and disease phenotypes (17, 57, 62).
To identify novel candidate functional variants in human
retinal CREs, we queried the sequence within these regions
from individuals with defined retinal pathologies. These indi-
viduals were selected as potentially carrying noncoding regu-
latory variants because they were found to be heterozygous for
a recessive coding pathogenic variant or loss-of-function allele
in a known disease gene that matched the disease phenotype. Our
hypothesis was that genetic variation within CREs associated with
these genes might contribute to the disease phenotype by further
lowering the effective dosage of the gene product. For several
different unrelated individuals, we identified noncoding variants in
the CREs of known retinal disease genes including RDH12,
ABCA4, and MYO7A.
Two such variants were identified in an active CRE at the
RDH12 locus in individuals with inherited retinal disease. Biallelic
mutations within the RDH12 coding sequence are known to
cause recessive Leber congenital amaurosis with severe childhood
retinal dystrophy (63). We found two active CREs at the RDH12
locus (Fig. 7C). The structure of this gene has been predicted to
span eight exons with the first exon being noncoding (RefSeq
NM_152443). We found no evidence of CRE accessibility or sig-
nificant DNA sequence conservation at the predicted promoter.
Instead we found accessibility at the start of the predicted second
exon near the start of the RDH12 ORF. Together with our total
RNA-seq reads, these data suggested an alternative promoter for
RDH12 in the adult human retina. At this candidate promoter, we
observed local enrichment for H3K27ac and binding of CRX,
OTX2, RORB, and MEF2D, albeit at moderate levels compared
to a nearby upstream enhancer (Fig. 7C).
At this prospective promoter, we found two separate variants in two
unrelated individuals,RDH12 c.-162G>A (hg38, chr14:67722482G>A)
and RDH12 c.-123C>T (hg38, chr14:67722520C>T) (reported in
ref. 64) (Fig. 7D). Neither of the variants was previously charac-
terized as deleterious, however c.-123C is conserved across simians
and c.-162A is conserved down to monotremes. We tested the
effect of these variants on the transcriptional activity of this CRE.
The consensus CRE demonstrates substantial promoter activity
in a plasmid-based reporter assay. However, when each SNP is
introduced individually, the activity of this region decreases by
∼50% and 80%, respectively (P < 0.001, n = 12, t test, two-tailed,
homoscedastic) (Fig. 7E).
We tested additional identified variants in the ABCA4 pro-
moter and an intronic ABCA4 enhancer and at an intronic
MYO7A enhancer. Several SNPs assayed at the ABCA4 pro-
moter had no discernable effect on reporter activity. Surpris-
ingly, however, two variants (rs11802887 and rs11806223) that
were found together in siblings affected by Stargardt disease
demonstrated increased reporter activity individually, with one
increase reaching significance (rs11802887) (P < 0.05, n = 4,
t test, two-tailed, homoscedastic) (SI Appendix, Fig. S7A). In
contrast, an ABCA4 enhancer variant (rs752024867; hg38
chr1:94,079,815T>G) found in an unrelated individual with
Stargardt disease showed a significant decrease in reporter
activity (P < 0.05, n = 4, t test, two-tailed, homoscedastic) (SI
Appendix, Fig. S7B). Finally, a distinct SNP found in a MYO7A
enhancer (chr11:77,172,048C>T) also demonstrated a signifi-
cant decrease in enhancer activity (P < 0.01, n = 4, t test, two-
tailed, homoscedastic) (SI Appendix, Fig. S7C). A common
theme among all of these variants is that they do not fall within
readily recognizable TF binding motifs; however, they do dem-
onstrate conservation across clades. This suggests that despite
reduced conservation in CREs compared to coding regions,
conservation may be predictive of vulnerable DNA sequences
within CREs that future studies could attribute directly to disease
phenotypes (3, 57).
Discussion
The majority of human genetic variation falls within noncoding
regions of the genome; however, these regions remain largely
uncharacterized and are not routinely screened for disease-causing
mutations. Genome-wide assays to identify CREs based on epi-
genetic signatures have greatly improved our understanding of
functional elements within the noncoding genome. In this study,
we identify CREs that are active in the adult human retina,
macula, and RPE/choroid, three tissue regions that are required
for vision and that are frequently affected in visual disorders. We
find that many of these CREs demonstrate tissue-specific DNA
accessibility and each tissue is enriched for a unique cohort of TF
binding motifs. Within the retina, we mapped the binding of five
TFs known to be required for photoreceptor function and rec-
ognized patterns of TF binding associated with CRE activity. We
identified putative cell type-specific CREs by generating single-cell
RNA-seq datasets to compare to our integrative epigenomic data.
Furthermore, our studies characterize CREs that harbor non-
coding variants that are associated with inherited visual disorders.
Our study focuses on adult human eye tissues and yields in-
sights into genetic regulation, complementing previous studies in
the mouse retina and the human retina (8–11, 35, 53, 65–67). By
comparing human and mouse data together, our studies shed
light on the evolution of noncoding regulatory elements in the
visual system, a remarkably well-conserved part of the CNS. By
comparing CRE landscapes derived from developmental and
adult datasets, it is possible to identify distinct CREs that drive
gene expression at each stage in retinal development and to map
the binding of TFs that constitute the core transcriptional reg-
ulatory circuitry of retinal differentiation. Perhaps most impor-
tantly by comparing between developing and adult CREs in the
human retina, it is possible to identify and test novel and known
genetic variants that are associated with developmental and later-
onset human visual diseases. Taken together, our data dem-
onstrate the utility of this integrative genomic approach for the
characterization of three complex human tissue regions that fa-
cilitate vision. This work fills important gaps in identifying and
characterizing the function of noncoding regulatory elements and
in providing a biologically relevant framework by which genetic
variants can be evaluated and understood.
Materials and Methods
Human and mouse tissue was procured according to protocols approved by
the Harvard Medical Area Institutional Review Board (IRB15-1457) and the
Harvard Medical Area (04572) and the Seattle Children’s Research Institute
(00050) Institutional Animal Care and Use Committees. High-throughput
epigenomic assays and luciferase assays were performed according to pub-
lished protocols. More detail regarding specific experimental procedures
and analyses are provided in SI Appendix.
Data Availability. All sequencing data generated for this study have been
deposited in the GEO database (accession no. GSE137311).
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